Capital Research Global Investors
Institutional investor · Portfolio as of Q2 2020
Top Holdings399 positions
Microsoft Corp. | 94.1M | $19.1B | 6.1% | $95.58 | +101.99% | 7 qtrssince 2018-Q4 | Increased 62 |
Netflix, Inc. | 34.1M | $15.5B | 4.9% | $27.84 | +63.45% | 7 qtrssince 2018-Q4 | Decreased 0 |
Meta Platforms Inc | 65.2M | $14.8B | 4.7% | $132.14 | +70.21% | 7 qtrssince 2018-Q4 | Decreased 0 |
Amazon.com, Inc. | 4.3M | $11.9B | 3.8% | $77.36 | +78.32% | 7 qtrssince 2018-Q4 | Decreased 0 |
Broadcom Inc | 32.2M | $10.2B | 3.2% | $21.98 | +26.23% | 7 qtrssince 2018-Q4 | Increased 64 |
GILEAD SCIENCES INC | 125.4M | $9.6B | 3.1% | $51.73 | +17.99% | 7 qtrssince 2018-Q4 | Increased 74 |
Abbott Laboratories | 87.4M | $8B | 2.5% | $63.02 | +29.21% | 7 qtrssince 2018-Q4 | Decreased 0 |
Amgen Inc. | 33.4M | $7.9B | 2.5% | $156.61 | +24.40% | 7 qtrssince 2018-Q4 | Increased 55 |
UnitedHealth Group Inc. | 22.9M | $6.8B | 2.1% | $227.85 | +16.11% | 7 qtrssince 2018-Q4 | Increased 55 |
Home Depot Inc. | 19.3M | $4.8B | 1.5% | $147.08 | +46.02% | 7 qtrssince 2018-Q4 | Decreased 0 |
MasterCard Incorporated | 16M | $4.7B | 1.5% | $188.03 | +51.74% | 7 qtrssince 2018-Q4 | Increased 53 |
AbbVie Inc. | 46.1M | $4.5B | 1.4% | $66.47 | +15.74% | 7 qtrssince 2018-Q4 | Decreased 0 |
Alphabet Inc. | 3.2M | $4.5B | 1.4% | $52.14 | +34.70% | 7 qtrssince 2018-Q4 | Increased 51 |
Thermo Fisher Scientific Inc | 11.7M | $4.2B | 1.3% | $219.16 | +62.57% | 7 qtrssince 2018-Q4 | Decreased 0 |
Alphabet Inc. | 2.8M | $4B | 1.3% | $52.44 | +33.53% | 7 qtrssince 2018-Q4 | Increased 54 |
Mercadolibre Inc | 3.9M | $3.9B | 1.2% | $389.67 | +152.98% | 7 qtrssince 2018-Q4 | Increased 52 |
EOG Resources Inc. | 71.3M | $3.6B | 1.1% | $59.53 | -35.92% | 7 qtrssince 2018-Q4 | Increased 58 |
Philip Morris International Inc. | 51.1M | $3.6B | 1.1% | $47.34 | +9.89% | 7 qtrssince 2018-Q4 | Increased 64 |
CSX CORP | 49.8M | $3.5B | 1.1% | $19.52 | +9.67% | 7 qtrssince 2018-Q4 | Increased 54 |
Autodesk Inc | 14.5M | $3.5B | 1.1% | $140.83 | +69.85% | 7 qtrssince 2018-Q4 | Decreased 0 |
Capital Research Global Investors manages $316.1B across 399 positions as of Q2 2020. Top holdings: MSFT (6.1%), NFLX (4.9%), META (4.7%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.
Active quarter - 40 new positions, 38 exits, 175 increased. Top move: GILD (INCREASED, conviction 74). Portfolio: $316.1B across 399 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR